Advertisement
33 - Cholesterol efflux and reverse cholesterol transport| Volume 235, ISSUE 2, e47-e48, August 2014

Effect of clinically used selective estrogen receptor modulators on macrophage cholesterol efflux and reverse cholesterol transport

DOI:https://doi.org/10.1016/j.atherosclerosis.2014.05.109
Effect of clinically used selective estrogen receptor modulators on macrophage cholesterol efflux and reverse cholesterol transport
Previous ArticleInhibition of NPC1L1 increases transintestinal cholesterol excretion (tice) dependent on Abcg5/g8 but independent of plasma Apob-containing lipoproteins
Next ArticleFatty acid manipulation of obesity – consequences for high-density lipoprotein protein composition and macrophage-to-feces reverse cholesterol transport (rct)
      Objectives: Selective estrogen receptor modulators (SERMs) are a class of drugs widely used to treat different disorders and symptoms. We have previously reported that tamoxifen interferes with the egress of LDL-derived cholesterol from late endosomes/lysosomes.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Publication history

      EAS-0742

      Identification

      DOI: https://doi.org/10.1016/j.atherosclerosis.2014.05.109

      Copyright

      © 2014 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX